Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Drug Substitution"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 292
Tytuł:
The sound stimulation method and EEG change analysis for development of digital therapeutics that can stimulate the nervous system: Cortical activation and drug substitution potential.
Autorzy:
Kim D; Department of Medical Biotechnology, Dongguk University-Bio Medi Campus, South Korea.
Woo J; Department of R&D Support, Research Institute for Commercialization of Biomedical Convergence Technology, Seoul, South Korea.
Jeong J; Research Institute for Commercialization of Biomedical Convergence Technology, Dongguk University, South Korea.
Kim S; Department of Medical Biotechnology, Dongguk University-Bio Medi Campus, South Korea.
Pokaż więcej
Źródło:
CNS neuroscience & therapeutics [CNS Neurosci Ther] 2023 Jan; Vol. 29 (1), pp. 402-411. Date of Electronic Publication: 2022 Nov 15.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Substitution*
Anesthesia*
Male ; Humans ; Female ; Young Adult ; Adult ; Electroencephalography ; Brain Stem ; Temporal Lobe
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of switching from adalimumab originator to adalimumab biosimilar in moderate to severe psoriasis patients: A Real-life experience in a tertiary referral centre.
Autorzy:
Gallo G; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Rostagno E; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Siliquini N; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Stroppiana E; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Verrone A; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Ortoncelli M; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Quaglino P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Dapavo P; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Ribero S; Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Pokaż więcej
Źródło:
The Australasian journal of dermatology [Australas J Dermatol] 2021 Aug; Vol. 62 (3), pp. e431-e432. Date of Electronic Publication: 2021 May 27.
Typ publikacji:
Letter
MeSH Terms:
Drug Substitution*
Tertiary Care Centers*
Adalimumab/*therapeutic use
Biosimilar Pharmaceuticals/*therapeutic use
Tumor Necrosis Factor Inhibitors/*therapeutic use
Adolescent ; Adult ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome ; Young Adult
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Switching antiepileptic drugs to once-daily dosing regimens in epilepsy patients.
Autorzy:
Kim SH; Department of Neurology, Konkuk University School of Medicine, Seoul, Korea.
Lee H; Department of Neurology, Konkuk University School of Medicine, Seoul, Korea.
Kim DW; Department of Neurology, Konkuk University School of Medicine, Seoul, Korea.
Pokaż więcej
Źródło:
Acta neurologica Scandinavica [Acta Neurol Scand] 2021 Jan; Vol. 143 (1), pp. 51-55. Date of Electronic Publication: 2020 Aug 26.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Medication Adherence*/psychology
Anticonvulsants/*administration & dosage
Drug Resistant Epilepsy/*drug therapy
Drug Resistant Epilepsy/*epidemiology
Drug Substitution/*methods
Adolescent ; Adult ; Aged ; Drug Administration Schedule ; Drug Resistant Epilepsy/psychology ; Drug Substitution/psychology ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens.
Autorzy:
Comer SD; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York.
Mannelli P; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina.
Alam D; Northwestern Medicine Central DuPage Hospital, Winfield, Illinois.
Douaihy A; Departments of Psychiatry and Medicine, Western Psychiatric Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Nangia N; Alkermes, Inc., Waltham, Massachusetts.
Akerman SC; Alkermes, Inc., Waltham, Massachusetts.
Zavod A; Alkermes, Inc., Waltham, Massachusetts.
Silverman BL; Alkermes, Inc., Waltham, Massachusetts.
Sullivan MA; Department of Psychiatry, Columbia University Irving Medical Center, New York, New York.; Alkermes, Inc., Waltham, Massachusetts.
Pokaż więcej
Źródło:
The American journal on addictions [Am J Addict] 2020 Jul; Vol. 29 (4), pp. 313-322. Date of Electronic Publication: 2020 Apr 04.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Buprenorphine*/administration & dosage
Buprenorphine*/adverse effects
Drug Substitution*/adverse effects
Drug Substitution*/methods
Naltrexone*/administration & dosage
Naltrexone*/adverse effects
Opioid-Related Disorders/*drug therapy
Adult ; Delayed-Action Preparations ; Dose-Response Relationship, Drug ; Drug Monitoring/methods ; Female ; Humans ; Male ; Narcotic Antagonists/administration & dosage ; Narcotic Antagonists/adverse effects ; Substance Withdrawal Syndrome/etiology ; Substance Withdrawal Syndrome/therapy ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The evidence for switching dibenzazepines in people with epilepsy.
Autorzy:
Watkins L; Swansea Bay University Health Board, Swansea, UK.
O'Dwyer M; School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, Ireland.
Oak K; Royal Cornwall Hospital Trust, Truro, UK.
Lawthom C; Aneurin Bevan University Health Board, Newport, UK.; Swansea University, Swansea, UK.
Maguire M; Leeds General Infirmary, Leeds, UK.; Leeds Institute of Biomedical & Clinical Sciences, University of Leeds, Leeds, UK.
Thomas R; Institute of Neuroscience, Newcastle University, Newcastle-upon-Tyne, UK.; Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.
Shankar R; Cornwall Partnership NHS Foundation Trust, Threemilestone Industrial Estate, Truro, UK.; University of Exeter Medical School, Knowledge Spa, Truro, UK.
Pokaż więcej
Źródło:
Acta neurologica Scandinavica [Acta Neurol Scand] 2020 Aug; Vol. 142 (2), pp. 121-130. Date of Electronic Publication: 2020 Apr 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Anticonvulsants/*therapeutic use
Carbamazepine/*therapeutic use
Dibenzazepines/*therapeutic use
Drug Substitution/*methods
Epilepsy/*drug therapy
Evidence-Based Medicine/*methods
Anticonvulsants/adverse effects ; Carbamazepine/adverse effects ; Dibenzazepines/adverse effects ; Drug Substitution/trends ; Epilepsy/diagnosis ; Evidence-Based Medicine/trends ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir.
Autorzy:
Viganò M; U.O. Epatologia, Ospedale San Giuseppe, University of Milan, Milan, Italy.
Loglio A; CRC 'A. M. e A. Migliavacca', Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Labanca S; U.O. Epatologia, Ospedale San Giuseppe, University of Milan, Milan, Italy.
Zaltron S; Clinica Malattie Infettive e Tropicali. Spedali Civili Brescia, University of Brescia, Brescia, Italy.
Castelli F; Clinica Malattie Infettive e Tropicali. Spedali Civili Brescia, University of Brescia, Brescia, Italy.
Andreone P; Dipartimento di Scienze Mediche e Chirurgiche, University of Bologna, Bologna, Italy.
Messina V; U.O.C. Malattie Infettive, A.O. S. Anna e S. Sebastiano, Caserta, Italy.
Ganga R; S.C Medicina Interna, Ospedale S. Michele A.O. Brotzu, Cagliari, Italy.
Coppola N; Malattie Infettive, Second University of Naples, Dipartimento Salute Mentale e Medicina Preventiva, Naples, Italy.
Marrone A; Dipartimento di Scienze Mediche, Chirurgiche, Neurologiche, Metaboliche e dell'Invecchiamento, Luigi Vanvitelli University of Campania, Naples, Italy.
Russello M; U.O.S. Epatologia e Malattie Gastroenteriche dell'A.R.N.A.S. Garibaldi-Nesima, Catania, Italy.
Marzano A; U.O. Gastroenterologia Universitaria, Ospedale San Giovanni Battista, Città della Salute e della Scienza di Torino, Turin, Italy.
Tucci A; U.O. Gastroenterologia Universitaria, Ospedale San Giovanni Battista, Città della Salute e della Scienza di Torino, Turin, Italy.
Taliani G; Unità di Malattie Infettive e Tropicali, Dipartimento di Medicina Clinica, Sapienza University, Rome, Italy.
Fasano M; UOC Malattie Infettive Ospedale F. Fallacara, Triggiano, Italy.
Fagiuoli S; Dipartimento di Gastroenterologia, Epatologia e Trapianto di Fegato, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Villa E; Divisione di Gastroenterologia, AOU Policlinico di Modena, University of Modena e Reggio Emilia, Modena, Italy.
Bronte F; Unità di Gastroenterologia ed Epatologia, DiBiMIS, University of Palermo, Palermo, Italy.
Santantonio T; Dipartimento di Medicina Clinica e Sperimentale, University of Foggia, Foggia, Italy.
Brancaccio G; Malattie Infettive, University of Padua, Padua, Italy.
Occhipinti V; U.O. Epatologia, Ospedale San Giuseppe, University of Milan, Milan, Italy.
Facchetti F; CRC 'A. M. e A. Migliavacca', Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Grossi G; CRC 'A. M. e A. Migliavacca', Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Rumi M; U.O. Epatologia, Ospedale San Giuseppe, University of Milan, Milan, Italy.
Lampertico P; CRC 'A. M. e A. Migliavacca', Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2019 Mar; Vol. 39 (3), pp. 484-493. Date of Electronic Publication: 2019 Jan 07.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Substitution*
Antiviral Agents/*administration & dosage
Antiviral Agents/*adverse effects
Guanine/*analogs & derivatives
Hepatitis B, Chronic/*drug therapy
Kidney/*drug effects
Kidney Diseases/*chemically induced
Tenofovir/*adverse effects
Adult ; Aged ; Aged, 80 and over ; Female ; Guanine/administration & dosage ; Guanine/adverse effects ; Hepatitis B, Chronic/diagnosis ; Humans ; Italy ; Kidney/physiopathology ; Kidney Diseases/diagnosis ; Kidney Diseases/physiopathology ; Male ; Middle Aged ; Recovery of Function ; Retrospective Studies ; Sustained Virologic Response ; Tenofovir/administration & dosage ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of etanercept for postoperative pyoderma gangrenosum after infliximab serum sickness.
Autorzy:
Ariane M; Assistance Publique- Hôpitaux de Paris, Département de Dermatologie, Hôpital Saint-Louis, Paris, France.
Bouaziz JD; Assistance Publique- Hôpitaux de Paris, Département de Dermatologie, Hôpital Saint-Louis, Paris, France.; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
de Masson A; Assistance Publique- Hôpitaux de Paris, Département de Dermatologie, Hôpital Saint-Louis, Paris, France.; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
Jachiet M; Assistance Publique- Hôpitaux de Paris, Département de Dermatologie, Hôpital Saint-Louis, Paris, France.; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
Bagot M; Assistance Publique- Hôpitaux de Paris, Département de Dermatologie, Hôpital Saint-Louis, Paris, France.; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
Lepelletier C; Assistance Publique- Hôpitaux de Paris, Département de Dermatologie, Hôpital Saint-Louis, Paris, France.; Université Paris-Diderot, Sorbonne Paris Cité, Paris, France.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2019 Jan; Vol. 32 (1), pp. e12774. Date of Electronic Publication: 2018 Nov 20.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Drug Substitution*
Dermatologic Agents/*administration & dosage
Dermatologic Agents/*adverse effects
Etanercept/*administration & dosage
Infliximab/*adverse effects
Mammaplasty/*adverse effects
Pyoderma Gangrenosum/*drug therapy
Serum Sickness/*chemically induced
Female ; Humans ; Middle Aged ; Pyoderma Gangrenosum/diagnosis ; Pyoderma Gangrenosum/etiology ; Serum Sickness/diagnosis ; Treatment Outcome
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A Survey of the Status of Methadone Switching in Japan Using a Hospital‐Based Administrative Claims Database.
Autorzy:
Imai, Shungo
Aoki, Natsumi
Ikegami, Keisuke
Kizaki, Hayato
Hori, Satoko
Pokaż więcej
Temat:
HOSPITALS
CANCER pain
GENERIC drug substitution
MULTIVARIATE analysis
AGE distribution
NONSTEROIDAL anti-inflammatory agents
TREATMENT duration
FENTANYL
DESCRIPTIVE statistics
RESEARCH funding
METHADONE hydrochloride
LOGISTIC regression analysis
OUTPATIENT services in hospitals
Źródło:
Journal of Clinical Pharmacology; Feb2024, Vol. 64 Issue 2, p189-195, 7p
Terminy geograficzne:
JAPAN
Czasopismo naukowe
Szczegóły
Tytuł:
Switching from infliximab innovator to biosimilar in patients with inflammatory bowel disease: a 12-month multicentre observational prospective cohort study.
Autorzy:
Schmitz EMH; Clinical Laboratory, Máxima Medical Center, Veldhoven, The Netherlands.; Expert Center Clinical Chemistry, Eindhoven, The Netherlands.; Clinical Laboratory, Catharina Hospital, Eindhoven, The Netherlands.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands.
Boekema PJ; Department of Gastroenterology, Máxima Medical Center, Eindhoven and Veldhoven, The Netherlands.
Straathof JWA; Department of Gastroenterology, Máxima Medical Center, Eindhoven and Veldhoven, The Netherlands.
van Renswouw DC; Department of Clinical Pharmacy, Elkerliek Hospital, Helmond, The Netherlands.
Brunsveld L; Expert Center Clinical Chemistry, Eindhoven, The Netherlands.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands.
Scharnhorst V; Expert Center Clinical Chemistry, Eindhoven, The Netherlands.; Clinical Laboratory, Catharina Hospital, Eindhoven, The Netherlands.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands.
van de Poll MEC; Department of Clinical Pharmacy and Pharmacology, Máxima Medical Center, Veldhoven, The Netherlands.
Broeren MAC; Clinical Laboratory, Máxima Medical Center, Veldhoven, The Netherlands.; Expert Center Clinical Chemistry, Eindhoven, The Netherlands.
Derijks LJJ; Department of Clinical Pharmacy and Pharmacology, Máxima Medical Center, Veldhoven, The Netherlands.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2018 Feb; Vol. 47 (3), pp. 356-363. Date of Electronic Publication: 2017 Dec 05.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Drug Substitution*
Biosimilar Pharmaceuticals/*therapeutic use
Gastrointestinal Agents/*therapeutic use
Inflammatory Bowel Diseases/*drug therapy
Infliximab/*therapeutic use
Adult ; Cohort Studies ; Female ; Follow-Up Studies ; Gastrointestinal Agents/immunology ; Humans ; Inflammatory Bowel Diseases/immunology ; Inflammatory Bowel Diseases/pathology ; Infliximab/immunology ; Male ; Middle Aged ; Remission Induction ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Switching to aflibercept versus continuing bevacizumab for treatment-resistant neovascular age-related macular degeneration: a one-year comparative observational study.
Autorzy:
Husum YS; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.
Moe MC; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Bragadóttir R; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Jørstad ØK; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
Acta ophthalmologica [Acta Ophthalmol] 2021 Dec; Vol. 99 (8), pp. e1354-e1359. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji:
Comparative Study; Journal Article; Observational Study
MeSH Terms:
Drug Resistance*
Bevacizumab/*administration & dosage
Drug Substitution/*methods
Macula Lutea/*diagnostic imaging
Receptors, Vascular Endothelial Growth Factor/*administration & dosage
Recombinant Fusion Proteins/*administration & dosage
Tomography, Optical Coherence/*methods
Wet Macular Degeneration/*drug therapy
Aged ; Angiogenesis Inhibitors/administration & dosage ; Female ; Humans ; Intravitreal Injections ; Male ; Retrospective Studies ; Treatment Outcome ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Wet Macular Degeneration/diagnosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Physicians' attitudes toward generic substitutions of antiseizure drugs in epilepsy.
Autorzy:
Olsson P; Department of Emergency Medicine, Helsingborg General Hospital, Helsingborg, Sweden.; Division of Clinical Sciences Helsingborg, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.
Freij J; Department of Specialized Medicine - Neurology, Helsingborg General Hospital, Helsingborg, Sweden.
Compagno Strandberg M; Department of Neurology, Rehabilitation Medicine, Memory Disorders and Geriatrics, Skåne University Hospital, Lund, Sweden.; Division of Neurology, Department of Clinical Neurosciences, Faculty of Medicine, Lund University, Lund, Sweden.
Adelöw C; Vällingby Neuro, Vällingby Medical Centre, Stockholm, Sweden.
Östlund H; Department of Neurology, Danderyd Hospital, Stockholm, Sweden.
Lindberger M; Department of Neurology, Danderyd Hospital, Stockholm, Sweden.
Källén K; Division of Clinical Sciences Helsingborg, Department of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund, Sweden.; Department of Specialized Medicine - Neurology, Helsingborg General Hospital, Helsingborg, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory Disorders and Geriatrics, Skåne University Hospital, Lund, Sweden.; Division of Neurology, Department of Clinical Neurosciences, Faculty of Medicine, Lund University, Lund, Sweden.
Pokaż więcej
Źródło:
Acta neurologica Scandinavica [Acta Neurol Scand] 2021 Nov; Vol. 144 (5), pp. 600-607. Date of Electronic Publication: 2021 Jul 17.
Typ publikacji:
Journal Article
MeSH Terms:
Epilepsy*/drug therapy
Physicians*
Anticonvulsants/therapeutic use ; Attitude ; Cross-Sectional Studies ; Drug Substitution ; Drugs, Generic/therapeutic use ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A national retrospective study of paediatric end-stage liver disease as a predictor of change to second-line therapy in children with autoimmune hepatitis.
Autorzy:
Zizzo AN; Division of Gastroenterology, Department of Paediatrics, London Children's Hospital, Western University, London, ON, Canada.
Jimenez-Rivera C; Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.
Kim J; Department of Medicine, University Health Network, University of Toronto,  Toronto, ON, Canada.
Schreiber RA; Division of Paediatric Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, University of British Columbia, Vancouver, BC, Canada.; Child and Family Research Institute, Vancouver, BC, Canada.
Ling SC; Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
Yap J; Division of Paediatric Gastroenterology and Nutrition, Department of Paediatrics, University of Alberta, Edmonton, AB, Canada.
Critch J; Department of Paediatrics, Faculty of Medicine, Memorial University, St. John's, NL, Canada.
Ahmed N; Division of Paediatric Gastroenterology and Nutrition, Montreal Children's Hospital, McGill University, Montreal, QC, Canada.
Alvarez F; Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Hôpital Sainte-Justine, Université de Montréal, Montreal, QC, Canada.
Kamath BM; Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Paediatrics, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Corporate Authors:
Canadian Paediatric Hepatology Research Group (CPHRG)
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2017 Oct; Vol. 37 (10), pp. 1562-1570. Date of Electronic Publication: 2017 Mar 15.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Decision Support Techniques*
Drug Substitution*
Hepatitis, Autoimmune/*diagnosis
Hepatitis, Autoimmune/*drug therapy
Immunosuppressive Agents/*therapeutic use
Adolescent ; Adrenal Cortex Hormones/therapeutic use ; Age Factors ; Area Under Curve ; Azathioprine/therapeutic use ; Canada ; Child ; Child, Preschool ; Databases, Factual ; Female ; Hepatitis, Autoimmune/blood ; Humans ; Immunosuppressive Agents/adverse effects ; International Normalized Ratio ; Male ; Predictive Value of Tests ; ROC Curve ; Retrospective Studies ; Risk Factors ; Time Factors ; Treatment Failure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.
Autorzy:
Luber RP; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
O'Neill R; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Singh S; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Sharma E; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Cunningham G; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Honap S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Meade S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Ray S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Anderson SH; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Mawdsley J; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Sanderson JD; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Samaan MA; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Arkir Z; Viapath Analytics, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Irving PM; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, King's College London, London, UK.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Sep; Vol. 54 (5), pp. 678-688. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Biosimilar Pharmaceuticals*/adverse effects
Inflammatory Bowel Diseases*/drug therapy
Pharmaceutical Preparations*
Drug Substitution ; Gastrointestinal Agents/adverse effects ; Humans ; Infliximab/therapeutic use ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
Autorzy:
Sadhasivam S; Vyome Biosciences Pvt. Ltd, Plot # 465, Ground Floor, F.I.E, Patparganj Industrial Area, Delhi, 110092, India.; Research Scholar, Research and Development Centre, Bharathiar University, Coimbatore, 641046, India.
Sinha M; Vyome Biosciences Pvt. Ltd, Plot # 465, Ground Floor, F.I.E, Patparganj Industrial Area, Delhi, 110092, India.
Saini S; Vyome Biosciences Pvt. Ltd, Plot # 465, Ground Floor, F.I.E, Patparganj Industrial Area, Delhi, 110092, India.
Kaur SP; Vyome Biosciences Pvt. Ltd, Plot # 465, Ground Floor, F.I.E, Patparganj Industrial Area, Delhi, 110092, India.
Gupta T; Maulana Azad Medical College & Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi, 110002, India.
Sengupta S; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts, USA.
Ghosh S; Vyome Biosciences Pvt. Ltd, Plot # 465, Ground Floor, F.I.E, Patparganj Industrial Area, Delhi, 110092, India.
Sardana K; Maulana Azad Medical College & Lok Nayak Hospital, Bahadur Shah Zafar Marg, New Delhi, 110002, India.
Pokaż więcej
Źródło:
Dermatologic therapy [Dermatol Ther] 2016 Nov; Vol. 29 (6), pp. 451-454. Date of Electronic Publication: 2016 Jul 18.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Drug Resistance, Bacterial*
Drug Substitution*
Acne Vulgaris/*drug therapy
Anti-Bacterial Agents/*therapeutic use
Fluoroquinolones/*therapeutic use
Minocycline/*therapeutic use
Propionibacterium acnes/*drug effects
Quinolizines/*therapeutic use
Skin/*drug effects
Acne Vulgaris/diagnosis ; Acne Vulgaris/microbiology ; Drug Therapy, Combination ; Genotype ; Humans ; Male ; Phenotype ; Phylogeny ; Propionibacterium acnes/classification ; Propionibacterium acnes/genetics ; Propionibacterium acnes/pathogenicity ; Remission Induction ; Ribotyping ; Skin/microbiology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Outcomes after double switching from originator Infliximab to biosimilar CT-P13 and biosimilar SB2 in patients with inflammatory bowel disease: a 12-month prospective cohort study.
Autorzy:
Trystram N; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
Abitbol V; Department of Gastroenterology, Cochin Hospital, AP-HP and University of Paris, Paris, France.
Tannoury J; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
Lecomte M; Department of Digestive Surgery, Cochin Hospital, AP-HP and University of Paris, Paris, France.
Assaraf J; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
Malamut G; Department of Gastroenterology, Cochin Hospital, AP-HP and University of Paris, Paris, France.
Gagnière C; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
Barré A; Department of Gastroenterology, Cochin Hospital, AP-HP and University of Paris, Paris, France.
Sobhani I; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
Chaussade S; Department of Gastroenterology, Cochin Hospital, AP-HP and University of Paris, Paris, France.
Amiot A; Department of Gastroenterology, Henri Mondor Hospital, AP-HP, EC2M3-EA 7375, Paris Est-Créteil (UPEC) Val de Marne University, Creteil, France.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Apr; Vol. 53 (8), pp. 887-899. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji:
Journal Article
MeSH Terms:
Biosimilar Pharmaceuticals*/adverse effects
Inflammatory Bowel Diseases*/drug therapy
Antibodies, Monoclonal ; Drug Substitution ; Humans ; Infliximab/therapeutic use ; Prospective Studies ; Treatment Outcome ; Tumor Necrosis Factor-alpha/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 292

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies